17-38961903-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001008777.3(FBXO47):āc.326C>Gā(p.Ala109Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001008777.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO47 | NM_001008777.3 | c.326C>G | p.Ala109Gly | missense_variant | 3/11 | ENST00000378079.3 | NP_001008777.2 | |
FBXO47 | XM_011524865.3 | c.248C>G | p.Ala83Gly | missense_variant | 3/11 | XP_011523167.1 | ||
FBXO47 | XM_011524867.3 | c.326C>G | p.Ala109Gly | missense_variant | 3/10 | XP_011523169.1 | ||
FBXO47 | XM_011524866.4 | c.181+942C>G | intron_variant | XP_011523168.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO47 | ENST00000378079.3 | c.326C>G | p.Ala109Gly | missense_variant | 3/11 | 1 | NM_001008777.3 | ENSP00000367319 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251214Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135802
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461662Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727162
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.326C>G (p.A109G) alteration is located in exon 3 (coding exon 2) of the FBXO47 gene. This alteration results from a C to G substitution at nucleotide position 326, causing the alanine (A) at amino acid position 109 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at